
Medina Pharmaceuticals Private Limited
About Medina Pharmaceuticals Private Limited
Data last updated:
Medina Pharmaceuticals Private Limited is a private limited company based in Thane, Maharashtra, India. It was incorporated on 11 July 2024.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U46497MH2024PTC428624.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Shahista Turab Shaikh and Jabin Faruk Shaikh.
Its last annual general meeting (AGM) was held on 31 December 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Thane, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹47,570. For the same year it recorded a net profit of ₹7,090 (net margin 14.9%) and EBITDA of ₹7,130 (EBITDA margin 15%).
Company details
Contact details
Medina Pharmaceuticals Private Limited's registered office is in Thane, Maharashtra.
- Registered AddressRoom No. 302 H No 246, Nerul, Thane, Maharashtra, India – 400706
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Medina Pharmaceuticals Private Limited
FY 2025 filings availableMedina Pharmaceuticals Private Limited reported revenue of ₹47,570 for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | ₹7,130 |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | ₹7,090 |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2024-25 |
|---|---|
| Profitability | |
| EBITDA Margin | 15% |
| Net Profit Margin | 14.9% |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Medina Pharmaceuticals Private Limited, buy the company report.
Board of directors of Medina Pharmaceuticals Private Limited
Medina Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shahista Turab Shaikh | Director | 11 Jul 2024 | 2 Years 4 Months | Current |
| Jabin Faruk Shaikh | Director | 11 Jul 2024 | 2 Years 4 Months | Current |
Peer comparison
Medina Pharmaceuticals Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Shakshansh Pharmaceuticals Private Limited | ₹49,643 (FY 2018) | Delhi, India | ||||
| Optimavibe Pharmaceuticals Private Limited | ₹49,100 (FY 2025) | Mirzapur Sadar, Uttar Pradesh, India | ||||
| Hermes Pharmaceuticals Private Limited | ₹48,035 (FY 2025) | -39.0% | Medak, Telangana, India | |||
| Pifer Pharmaceuticals Pvt Ltd | ₹48,000 (FY 2024) | Punjab, India | ||||
| Pills and Potion Pharmaceuticals Private Limited | ₹47,864 (FY 2023) | 15.0% | New Delhi, Delhi, India | |||
| Medina Pharmaceuticals Private Limitedthis company | ₹47,570 (FY 2025) | ₹7,090 | 14.9% | Thane, Maharashtra, India | ||
| Dr. Remedies Pharmaceuticals Private Limited | ₹47,255 (FY 2025) | Hyderabad, Telangana, India | ||||
| International Genetics Pharmaceuticals (OPC) Private Limited | ₹47,210 (FY 2025) | -34.0% | Indore, Madhya Pradesh, India | |||
| Tutis Pharmaceuticals Private Limited | ₹47,148 (FY 2020) | -84.0% | Kozhikode, Kerala, India | |||
| Chiga Pharmaceuticals Private Limited | ₹46,516 (FY 2024) | 498.0% | Bettiah, Bihar, India | |||
| Healto Pharmaceuticals Private Limited | ₹46,290 (FY 2022) | Hyderabad, Telangana, India |
To see the full peer comparison of Medina Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Medina Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medina Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Medina Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Medina Pharmaceuticals Private Limited has 2 board changes on record since 2024: 2 appointments. The latest: Jabin Faruk Shaikh was appointed as Director on 11 Jul 2024.
Frequently asked questions
Medina Pharmaceuticals is an active private limited company based in Thane, Maharashtra, India. It was incorporated on 11 July 2024 (2+ years old) and is registered under CIN U46497MH2024PTC428624.
Medina Pharmaceuticals has 2 current directors:
- Shahista Turab Shaikh - Director
- Jabin Faruk Shaikh - Director
The latest financial statements of Medina Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 31 December 2025. Year-wise statements from FY 2025 are in the company report.
The CIN (Corporate Identification Number) of Medina Pharmaceuticals is U46497MH2024PTC428624. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medina Pharmaceuticals was incorporated on 11 July 2024, making it 2+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Medina Pharmaceuticals by revenue are Shakshansh Pharmaceuticals Private Limited, Optimavibe Pharmaceuticals Private Limited, Hermes Pharmaceuticals Private Limited, Pifer Pharmaceuticals Pvt Ltd, Pills and Potion Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Jabin Faruk Shaikh was appointed as Director on 11 Jul 2024. Shahista Turab Shaikh was appointed as Director on 11 Jul 2024.
The registered office of Medina Pharmaceuticals is at Room No. 302 H No 246, Nerul, Thane, Maharashtra, India – 400706.
Medina Pharmaceuticals can be reached at its registered office: Room No. 302 H No 246, Nerul, Thane, Maharashtra, India – 400706.
Medina Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Mumbai.

